| 0 |
MICRODONTIA |
1 |
0.2500 |
| 1 |
URAEMIA ODOUR |
1 |
0.1250 |
| 2 |
BRONCHITIS PNEUMOCOCCAL |
1 |
0.0476 |
| 3 |
TOOTH HYPOPLASIA |
8 |
0.0460 |
| 4 |
CHEST SCAN ABNORMAL |
1 |
0.0303 |
| 5 |
ENAMEL ANOMALY |
8 |
0.0280 |
| 6 |
SARCOMATOID MESOTHELIOMA |
1 |
0.0133 |
| 7 |
ABDOMINAL WALL CYST |
1 |
0.0082 |
| 8 |
BLADDER CYST |
1 |
0.0062 |
| 9 |
SCHWANNOMA |
1 |
0.0050 |
| 10 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
7 |
0.0050 |
| 11 |
MUCORMYCOSIS |
11 |
0.0042 |
| 12 |
MORAXELLA INFECTION |
1 |
0.0036 |
| 13 |
NERVE ROOT COMPRESSION |
2 |
0.0035 |
| 14 |
ABDOMINAL WALL DISORDER |
1 |
0.0034 |
| 15 |
MALOCCLUSION |
1 |
0.0034 |
| 16 |
POSITIVE AIRWAY PRESSURE THERAPY |
1 |
0.0034 |
| 17 |
HAEMATOLOGY TEST ABNORMAL |
1 |
0.0031 |
| 18 |
CHRONIC RESPIRATORY DISEASE |
1 |
0.0028 |
| 19 |
VAGINAL FISTULA |
1 |
0.0028 |
| 20 |
CANCER PAIN |
7 |
0.0027 |
| 21 |
LUNG CYST |
1 |
0.0025 |
| 22 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
7 |
0.0025 |
| 23 |
PSEUDOMONAS TEST POSITIVE |
2 |
0.0024 |
| 24 |
FUNGAL FOOT INFECTION |
1 |
0.0023 |
| 25 |
CARBON DIOXIDE INCREASED |
3 |
0.0022 |
| 26 |
GALLBLADDER RUPTURE |
1 |
0.0022 |
| 27 |
TUBERCULOUS PLEURISY |
1 |
0.0021 |
| 28 |
CHRONIC GRAFT VERSUS HOST DISEASE |
7 |
0.0019 |
| 29 |
BLOOD IMMUNOGLOBULIN M INCREASED |
1 |
0.0016 |
| 30 |
DRY GANGRENE |
1 |
0.0016 |
| 31 |
MESOTHELIOMA |
2 |
0.0015 |
| 32 |
BRONCHOPULMONARY ASPERGILLOSIS |
11 |
0.0014 |
| 33 |
JUDGEMENT IMPAIRED |
2 |
0.0014 |
| 34 |
HEAT EXHAUSTION |
1 |
0.0012 |
| 35 |
SPUTUM CULTURE POSITIVE |
1 |
0.0012 |
| 36 |
EXPOSURE TO CHEMICAL POLLUTION |
2 |
0.0012 |
| 37 |
RELAPSING-REMITTING MULTIPLE SCLEROSIS |
1 |
0.0012 |
| 38 |
RED BLOOD CELL COUNT INCREASED |
3 |
0.0011 |
| 39 |
DENTAL CARE |
2 |
0.0011 |
| 40 |
PHARYNGEAL HYPOAESTHESIA |
1 |
0.0011 |
| 41 |
TELANGIECTASIA |
1 |
0.0010 |
| 42 |
HYPERVIGILANCE |
1 |
0.0010 |
| 43 |
REDUCED FACIAL EXPRESSION |
1 |
0.0010 |
| 44 |
BLOOD CREATININE DECREASED |
3 |
0.0010 |
| 45 |
STAPHYLOCOCCUS TEST POSITIVE |
2 |
0.0009 |
| 46 |
PO2 DECREASED |
1 |
0.0009 |
| 47 |
CHEMICAL BURN |
1 |
0.0009 |
| 48 |
GROIN ABSCESS |
1 |
0.0008 |
| 49 |
DEVICE DISPENSING ERROR |
1 |
0.0008 |
| 50 |
GLUCOSE URINE PRESENT |
1 |
0.0008 |
| 51 |
LIPOMA |
2 |
0.0008 |
| 52 |
SINUS ARRHYTHMIA |
1 |
0.0008 |
| 53 |
TUMOUR PAIN |
1 |
0.0008 |
| 54 |
BLOOD POTASSIUM INCREASED |
12 |
0.0007 |
| 55 |
RASH MORBILLIFORM |
2 |
0.0007 |
| 56 |
CONTRAINDICATION TO MEDICAL TREATMENT |
1 |
0.0007 |
| 57 |
URINE KETONE BODY PRESENT |
1 |
0.0006 |
| 58 |
OEDEMA MOUTH |
2 |
0.0006 |
| 59 |
METABOLIC SYNDROME |
1 |
0.0006 |
| 60 |
ANTIBODY TEST POSITIVE |
1 |
0.0006 |
| 61 |
CERVICAL SPINAL STENOSIS |
1 |
0.0006 |
| 62 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
3 |
0.0006 |
| 63 |
PNEUMONIA KLEBSIELLA |
1 |
0.0005 |
| 64 |
INJECTION SITE CELLULITIS |
1 |
0.0005 |
| 65 |
TRAUMATIC LUNG INJURY |
1 |
0.0005 |
| 66 |
LATENT TUBERCULOSIS |
1 |
0.0005 |
| 67 |
ABSCESS LIMB |
2 |
0.0005 |
| 68 |
TOOTH DISORDER |
10 |
0.0004 |
| 69 |
HAEMATOCRIT INCREASED |
1 |
0.0004 |
| 70 |
GRAFT VERSUS HOST DISEASE |
3 |
0.0004 |
| 71 |
WRONG DOSE |
1 |
0.0004 |
| 72 |
BREATH ODOUR |
1 |
0.0004 |
| 73 |
HYPERVOLAEMIA |
2 |
0.0004 |
| 74 |
INJECTION SITE ABSCESS |
1 |
0.0004 |
| 75 |
SKIN LESION |
11 |
0.0004 |
| 76 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 77 |
TEMPOROMANDIBULAR JOINT SYNDROME |
1 |
0.0004 |
| 78 |
CHOLECYSTITIS INFECTIVE |
1 |
0.0004 |
| 79 |
LUMBAR SPINAL STENOSIS |
1 |
0.0003 |
| 80 |
CREPITATIONS |
1 |
0.0003 |
| 81 |
BRONCHIECTASIS |
2 |
0.0003 |
| 82 |
DEPRESSION SUICIDAL |
1 |
0.0003 |
| 83 |
TACHYPHRENIA |
1 |
0.0003 |
| 84 |
WOUND |
8 |
0.0003 |
| 85 |
CARPAL TUNNEL SYNDROME |
4 |
0.0003 |
| 86 |
THERMAL BURN |
2 |
0.0003 |
| 87 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 88 |
CAROTID ARTERY OCCLUSION |
1 |
0.0003 |
| 89 |
RASH ERYTHEMATOUS |
13 |
0.0003 |
| 90 |
TENDON INJURY |
1 |
0.0003 |
| 91 |
MUCOSAL INFLAMMATION |
7 |
0.0003 |
| 92 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 93 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 94 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 95 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 96 |
BLOOD UREA INCREASED |
4 |
0.0002 |
| 97 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 98 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 99 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
1 |
0.0002 |
| 100 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 101 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 102 |
NERVE COMPRESSION |
2 |
0.0002 |
| 103 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
0.0002 |
| 104 |
SPUTUM DISCOLOURED |
2 |
0.0002 |
| 105 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 106 |
KNEE OPERATION |
2 |
0.0002 |
| 107 |
DIABETIC NEUROPATHY |
1 |
0.0002 |
| 108 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 109 |
C-REACTIVE PROTEIN INCREASED |
7 |
0.0002 |
| 110 |
PHARYNGOLARYNGEAL PAIN |
1 |
0.0002 |
| 111 |
INTERVERTEBRAL DISC PROTRUSION |
4 |
0.0002 |
| 112 |
ASTHENOPIA |
1 |
0.0002 |
| 113 |
CHOKING SENSATION |
1 |
0.0002 |
| 114 |
DRUG LEVEL INCREASED |
3 |
0.0002 |
| 115 |
PERONEAL NERVE PALSY |
1 |
0.0002 |
| 116 |
HYPERTONIA |
1 |
0.0002 |
| 117 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 118 |
SINUS HEADACHE |
1 |
0.0002 |
| 119 |
GANGRENE |
1 |
0.0002 |
| 120 |
CYST |
2 |
0.0002 |
| 121 |
OLIGURIA |
1 |
0.0002 |
| 122 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
4 |
0.0002 |
| 123 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 124 |
SCREAMING |
1 |
0.0002 |
| 125 |
ENTERITIS |
1 |
0.0002 |
| 126 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 127 |
DYSGRAPHIA |
1 |
0.0002 |
| 128 |
WALKING AID USER |
1 |
0.0002 |
| 129 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
2 |
0.0001 |
| 130 |
DISSEMINATED INTRAVASCULAR COAGULATION |
2 |
0.0001 |
| 131 |
PAPULE |
1 |
0.0001 |
| 132 |
FAECES SOFT |
1 |
0.0001 |
| 133 |
BONE PAIN |
8 |
0.0001 |
| 134 |
PULMONARY MASS |
2 |
0.0001 |
| 135 |
ECONOMIC PROBLEM |
2 |
0.0001 |
| 136 |
RENAL IMPAIRMENT |
11 |
0.0001 |
| 137 |
RENAL FAILURE CHRONIC |
1 |
0.0001 |
| 138 |
TENDONITIS |
2 |
0.0001 |
| 139 |
DRUG SCREEN POSITIVE |
1 |
0.0001 |
| 140 |
FURUNCLE |
1 |
0.0001 |
| 141 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 142 |
RENAL CYST |
1 |
0.0001 |
| 143 |
SCIATICA |
2 |
0.0001 |
| 144 |
DECUBITUS ULCER |
1 |
0.0001 |
| 145 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 146 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 147 |
ERECTILE DYSFUNCTION |
3 |
0.0001 |
| 148 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 149 |
GASTROINTESTINAL DISORDER |
10 |
0.0001 |
| 150 |
LEUKOCYTOSIS |
2 |
0.0001 |
| 151 |
LIP DRY |
1 |
0.0001 |
| 152 |
END STAGE RENAL DISEASE |
2 |
0.0001 |
| 153 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 154 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 155 |
HAEMOPTYSIS |
3 |
0.0001 |
| 156 |
DEFORMITY |
1 |
0.0001 |
| 157 |
PHOTOPHOBIA |
2 |
0.0001 |
| 158 |
WHITE BLOOD CELL COUNT INCREASED |
4 |
0.0001 |
| 159 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 160 |
DYSSTASIA |
3 |
0.0001 |
| 161 |
PARKINSONISM |
1 |
0.0001 |
| 162 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 163 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 164 |
EMPHYSEMA |
1 |
0.0001 |
| 165 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 166 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 167 |
RIB FRACTURE |
2 |
0.0001 |
| 168 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 169 |
POLLAKIURIA |
4 |
0.0001 |
| 170 |
INCONTINENCE |
1 |
0.0001 |
| 171 |
RENAL PAIN |
1 |
0.0001 |
| 172 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 173 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 174 |
MICTURITION URGENCY |
1 |
0.0001 |
| 175 |
MYOCARDITIS |
1 |
0.0001 |
| 176 |
NEOPLASM |
1 |
0.0001 |
| 177 |
SHOCK |
2 |
0.0001 |
| 178 |
SPLENOMEGALY |
1 |
0.0001 |
| 179 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 180 |
NEUROLEPTIC MALIGNANT SYNDROME |
1 |
0.0001 |
| 181 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 182 |
ATAXIA |
1 |
0.0001 |
| 183 |
WRIST FRACTURE |
1 |
0.0001 |
| 184 |
HEPATITIS C |
1 |
0.0001 |
| 185 |
NOCTURIA |
1 |
0.0001 |
| 186 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 187 |
ANOREXIA |
1 |
0.0001 |
| 188 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 189 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 190 |
OEDEMA |
4 |
0.0001 |
| 191 |
LYMPHOPENIA |
1 |
0.0001 |
| 192 |
PAIN IN JAW |
2 |
0.0001 |
| 193 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 194 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 195 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 196 |
RENAL INJURY |
2 |
0.0001 |
| 197 |
CATARACT |
4 |
0.0001 |
| 198 |
CHRONIC KIDNEY DISEASE |
5 |
0.0001 |
| 199 |
OEDEMA PERIPHERAL |
8 |
0.0001 |
| 200 |
INSURANCE ISSUE |
1 |
0.0001 |
| 201 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 202 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 203 |
THYROID DISORDER |
1 |
0.0001 |
| 204 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 205 |
ANKLE FRACTURE |
1 |
0.0001 |
| 206 |
LUNG INFECTION |
1 |
0.0001 |
| 207 |
COGNITIVE DISORDER |
3 |
0.0001 |
| 208 |
SWOLLEN TONGUE |
2 |
0.0001 |
| 209 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 210 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 211 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 212 |
CYSTITIS |
2 |
0.0001 |
| 213 |
OBESITY |
1 |
0.0001 |
| 214 |
IMPAIRED HEALING |
2 |
0.0001 |
| 215 |
MULTIPLE FRACTURES |
1 |
0.0001 |
| 216 |
TYPE 2 DIABETES MELLITUS |
2 |
0.0001 |
| 217 |
FACE OEDEMA |
1 |
0.0001 |
| 218 |
DISEASE PROGRESSION |
7 |
0.0001 |
| 219 |
ACUTE KIDNEY INJURY |
9 |
0.0001 |
| 220 |
SCAR |
1 |
0.0001 |
| 221 |
HYPERKALAEMIA |
2 |
0.0001 |
| 222 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 223 |
BRADYCARDIA |
3 |
0.0001 |
| 224 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 225 |
RASH PRURITIC |
3 |
0.0001 |
| 226 |
HEPATIC STEATOSIS |
1 |
0.0001 |
| 227 |
NECK PAIN |
3 |
0.0001 |
| 228 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 229 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 230 |
FLATULENCE |
3 |
0.0001 |
| 231 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 232 |
DIABETES MELLITUS |
4 |
0.0001 |
| 233 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 234 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 235 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 236 |
KIDNEY INFECTION |
1 |
0.0001 |
| 237 |
DISABILITY |
1 |
0.0001 |
| 238 |
SINUS DISORDER |
1 |
0.0001 |
| 239 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 240 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 241 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 242 |
PERITONITIS |
1 |
0.0000 |
| 243 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 244 |
EATING DISORDER |
1 |
0.0000 |
| 245 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 246 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 247 |
AMNESIA |
3 |
0.0000 |
| 248 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 249 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 250 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 251 |
ANGIOEDEMA |
2 |
0.0000 |
| 252 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 253 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 254 |
BACK PAIN |
10 |
0.0000 |
| 255 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 256 |
BURNING SENSATION |
3 |
0.0000 |
| 257 |
LOCALISED INFECTION |
1 |
0.0000 |
| 258 |
NEURALGIA |
1 |
0.0000 |
| 259 |
ARTHRALGIA |
17 |
0.0000 |
| 260 |
LUNG DISORDER |
2 |
0.0000 |
| 261 |
LIVER INJURY |
1 |
0.0000 |
| 262 |
ABASIA |
1 |
0.0000 |
| 263 |
AGEUSIA |
1 |
0.0000 |
| 264 |
HYPOPHAGIA |
1 |
0.0000 |
| 265 |
HEPATITIS |
1 |
0.0000 |
| 266 |
SINUSITIS |
4 |
0.0000 |
| 267 |
DRUG RESISTANCE |
1 |
0.0000 |
| 268 |
SKIN ULCER |
1 |
0.0000 |
| 269 |
RASH GENERALISED |
1 |
0.0000 |
| 270 |
PHARMACEUTICAL PRODUCT COMPLAINT |
1 |
0.0000 |
| 271 |
DIPLOPIA |
1 |
0.0000 |
| 272 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 273 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 274 |
ARTHRITIS |
3 |
0.0000 |
| 275 |
ANHEDONIA |
1 |
0.0000 |
| 276 |
DRUG INTERACTION |
6 |
0.0000 |
| 277 |
PNEUMONITIS |
1 |
0.0000 |
| 278 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 279 |
URTICARIA |
6 |
0.0000 |
| 280 |
BLISTER |
2 |
0.0000 |
| 281 |
TARDIVE DYSKINESIA |
1 |
0.0000 |
| 282 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 283 |
DEPRESSION |
8 |
0.0000 |
| 284 |
HYPERSOMNIA |
1 |
0.0000 |
| 285 |
BALANCE DISORDER |
3 |
0.0000 |
| 286 |
ASCITES |
1 |
0.0000 |
| 287 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 288 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 289 |
SWELLING |
3 |
0.0000 |
| 290 |
HEAD INJURY |
1 |
0.0000 |
| 291 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 292 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 293 |
HIP FRACTURE |
1 |
0.0000 |
| 294 |
RHINORRHOEA |
2 |
0.0000 |
| 295 |
PNEUMONIA |
10 |
0.0000 |
| 296 |
EYE DISORDER |
1 |
0.0000 |
| 297 |
RENAL FAILURE |
4 |
0.0000 |
| 298 |
LIP SWELLING |
1 |
0.0000 |
| 299 |
FUNGAL INFECTION |
1 |
0.0000 |
| 300 |
SKIN DISORDER |
1 |
0.0000 |
| 301 |
URINARY RETENTION |
1 |
0.0000 |
| 302 |
GAIT INABILITY |
1 |
0.0000 |
| 303 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 304 |
ERYTHEMA |
6 |
0.0000 |
| 305 |
MULTIPLE SCLEROSIS RELAPSE |
2 |
0.0000 |
| 306 |
NIGHTMARE |
1 |
0.0000 |
| 307 |
RASH MACULAR |
1 |
0.0000 |
| 308 |
HYPOXIA |
1 |
0.0000 |
| 309 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 310 |
MOBILITY DECREASED |
2 |
0.0000 |
| 311 |
DRUG EFFECT INCOMPLETE |
1 |
0.0000 |
| 312 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 313 |
UNDERDOSE |
2 |
0.0000 |
| 314 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 315 |
DYSURIA |
1 |
0.0000 |
| 316 |
DYSARTHRIA |
1 |
0.0000 |
| 317 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 318 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 319 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 320 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 321 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 322 |
JOINT SWELLING |
3 |
0.0000 |
| 323 |
DIARRHOEA |
16 |
0.0000 |
| 324 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 325 |
DRY MOUTH |
2 |
0.0000 |
| 326 |
DYSKINESIA |
1 |
0.0000 |
| 327 |
BLINDNESS |
1 |
0.0000 |
| 328 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 329 |
OSTEOPOROSIS |
1 |
0.0000 |
| 330 |
PRODUCT USE IN UNAPPROVED INDICATION |
6 |
0.0000 |
| 331 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 332 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 333 |
MYALGIA |
4 |
0.0000 |
| 334 |
PRURITUS |
9 |
0.0000 |
| 335 |
SEPTIC SHOCK |
1 |
0.0000 |
| 336 |
DEHYDRATION |
3 |
0.0000 |
| 337 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 338 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 339 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 340 |
SKIN IRRITATION |
1 |
0.0000 |
| 341 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 342 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 343 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 344 |
RENAL DISORDER |
1 |
0.0000 |
| 345 |
VOMITING |
10 |
0.0000 |
| 346 |
ARRHYTHMIA |
1 |
0.0000 |
| 347 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 348 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 349 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 350 |
HEADACHE |
13 |
0.0000 |
| 351 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 352 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 353 |
PAIN IN EXTREMITY |
6 |
0.0000 |
| 354 |
DYSPEPSIA |
2 |
0.0000 |
| 355 |
HEART RATE INCREASED |
2 |
0.0000 |
| 356 |
DRY EYE |
1 |
0.0000 |
| 357 |
LEUKOPENIA |
1 |
0.0000 |
| 358 |
AGGRESSION |
1 |
0.0000 |
| 359 |
HYPOTENSION |
4 |
0.0000 |
| 360 |
THERAPY CESSATION |
1 |
0.0000 |
| 361 |
DYSPNOEA |
11 |
0.0000 |
| 362 |
PANCREATITIS |
1 |
0.0000 |
| 363 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 364 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 365 |
RASH |
8 |
0.0000 |
| 366 |
CONSTIPATION |
4 |
0.0000 |
| 367 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 368 |
TREMOR |
3 |
0.0000 |
| 369 |
HYPONATRAEMIA |
1 |
0.0000 |
| 370 |
ANXIETY |
5 |
0.0000 |
| 371 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 372 |
PALPITATIONS |
2 |
0.0000 |
| 373 |
CHILLS |
2 |
0.0000 |
| 374 |
SURGERY |
1 |
0.0000 |
| 375 |
WHEEZING |
1 |
0.0000 |
| 376 |
FATIGUE |
13 |
0.0000 |
| 377 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 378 |
STOMATITIS |
1 |
0.0000 |
| 379 |
CONDITION AGGRAVATED |
5 |
0.0000 |
| 380 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 381 |
VERTIGO |
1 |
0.0000 |
| 382 |
DISCOMFORT |
1 |
0.0000 |
| 383 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 384 |
SWELLING FACE |
1 |
0.0000 |
| 385 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 386 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 387 |
FALL |
5 |
0.0000 |
| 388 |
INSOMNIA |
4 |
0.0000 |
| 389 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 390 |
NEUTROPENIA |
2 |
0.0000 |
| 391 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 392 |
VISION BLURRED |
2 |
0.0000 |
| 393 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 394 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 395 |
SLEEP DISORDER |
1 |
0.0000 |
| 396 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 397 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 398 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 399 |
BRONCHITIS |
1 |
0.0000 |
| 400 |
EPISTAXIS |
1 |
0.0000 |
| 401 |
HYPOAESTHESIA |
2 |
0.0000 |
| 402 |
ASTHENIA |
5 |
0.0000 |
| 403 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 404 |
HOSPITALISATION |
2 |
0.0000 |
| 405 |
NAUSEA |
10 |
0.0000 |
| 406 |
OFF LABEL USE |
11 |
0.0000 |
| 407 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 408 |
THROMBOSIS |
1 |
0.0000 |
| 409 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 410 |
DIZZINESS |
6 |
0.0000 |
| 411 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 412 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 413 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 414 |
PYREXIA |
4 |
0.0000 |
| 415 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 416 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 417 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 418 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 419 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 420 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 421 |
PAIN |
6 |
0.0000 |
| 422 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 423 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 424 |
HAEMORRHAGE |
1 |
0.0000 |
| 425 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 426 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 427 |
MALAISE |
4 |
0.0000 |
| 428 |
INFLUENZA |
1 |
0.0000 |
| 429 |
SEPSIS |
1 |
0.0000 |
| 430 |
WEIGHT INCREASED |
2 |
0.0000 |
| 431 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 432 |
SEIZURE |
1 |
0.0000 |
| 433 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 434 |
DECREASED APPETITE |
2 |
0.0000 |
| 435 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 436 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 437 |
HYPERHIDROSIS |
1 |
0.0000 |
| 438 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 439 |
WEIGHT DECREASED |
2 |
0.0000 |
| 440 |
COUGH |
2 |
0.0000 |
| 441 |
DRUG INEFFECTIVE |
8 |
0.0000 |
| 442 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 443 |
COVID-19 |
1 |
0.0000 |
| 444 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 445 |
MUSCLE SPASMS |
1 |
0.0000 |
| 446 |
CHEST PAIN |
1 |
0.0000 |
| 447 |
HYPERTENSION |
1 |
0.0000 |
| 448 |
FEELING ABNORMAL |
1 |
0.0000 |
| 449 |
DEATH |
3 |
0.0000 |
| 450 |
INJECTION SITE PAIN |
1 |
0.0000 |